首站-论文投稿智能助手
典型文献
Characteristic analysis of skin keratinocytes in patients with type 2 diabetes based on the single-cell levels
文献摘要:
Background::Keratinocytes play an important role in wound healing; however, less is known about skin keratinocytes in patients with type 2 diabetes mellitus (T2DM). Therefore, this study aimed to search for the transcriptional characteristics of keratinocytes at the single-cell level from T2DM patients, and to provide experimental data for identifying the pathological mechanisms of keratinocytes under pathological conditions.Methods::We performed single-cell RNA sequencing on the skin tissue from two T2DM patients and one patient without diabetes-induced trauma using the BD Rhapsody TM Single-Cell Analysis System. With the help of bioinformatics R-based single-cell analysis software, we analyzed the results of single-cell sequencing to identify the single-cell subsets and transcriptional characteristics of keratinocytes at the single-cell level, including Kyoto Encyclopedia of Genes and Genomes and Gene Ontology analyzes. Results::In this study, we found specific highly expressed signature keratinocyte-related genes. We analyzed the transcriptome of keratinocytes from experimental and control groups and screened a total of 356 differential genes, which were subject to bioinformatics analysis. Enriched pathways included oxidative phosphorylation, antigen processing and presentation, prion and Huntingtons’ diseases, bacterial invasion of epithelial cells, thermogenesis, vasopressin-regulated water reabsorption, and protein processing in the endoplasmic reticulum.Conclusions::This study revealed the characteristics of keratinocytes at the single-cell level and screened a group of differentially expressed genes related to T2DM-associated keratinocytes, oxidative phosphorylation, cytokine receptor interactions, prion diseases, and other signaling pathways.
文献关键词:
Diabetes mellitus, type 2;Gene Ontology;Keratinocytes;Prion diseases;Sequence analysis, RNA;Single-cell analysis;Transcriptome;Wound healing
作者姓名:
Liao Bingye;Ouyang Qiuyi;Song Hongqin;Wang Ziqi;Ou Jinhua;Huang Jinxin;Liu Liang
作者机构:
Department of Operating Room, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, China;Wound Treatment Department, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong 510315, China
引用格式:
[1]Liao Bingye;Ouyang Qiuyi;Song Hongqin;Wang Ziqi;Ou Jinhua;Huang Jinxin;Liu Liang-.Characteristic analysis of skin keratinocytes in patients with type 2 diabetes based on the single-cell levels)[J].中华医学杂志(英文版),2022(20):2461-2466
A类:
Keratinocytes,Rhapsody ,Huntingtons,thermogenesis
B类:
Characteristic,analysis,skin,keratinocytes,patients,type,diabetes,single,levels,Background,play,important,role,wound,healing,however,less,known,about,mellitus,T2DM,Therefore,this,study,aimed,search,transcriptional,characteristics,from,provide,experimental,data,identifying,pathological,mechanisms,under,conditions,Methods,We,performed,sequencing,tissue,two,one,without,induced,trauma,using,BD,TM,Single,Cell,Analysis,System,With,help,bioinformatics,software,analyzed,results,subsets,including,Kyoto,Encyclopedia,Genes,Genomes,Ontology,analyzes,Results,In,found,specific,highly,expressed,signature,related,transcriptome,control,groups,screened,total,which,were,subject,Enriched,pathways,included,oxidative,phosphorylation,antigen,processing,presentation,prion,diseases,bacterial,invasion,epithelial,cells,vasopressin,regulated,water,reabsorption,protein,endoplasmic,reticulum,Conclusions,This,revealed,differentially,associated,cytokine,receptor,interactions,other,signaling,Diabetes,Prion,Sequence,Transcriptome,Wound
AB值:
0.50864
相似文献
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Jia Lu;Ting Li;Zhichao Liao;Hui Yu;Yongtian Zhao;Haixiao Wu;Zhiwu Ren;Jun Zhao;Ruwei Xing;Sheng Teng;Yun Yang;Xiangchun Li;Kexin Chen;Jonathan Trent;Jilong Yang-Department of Bone and Soft Tissue Tumor,2Department of Infection Management,3Key Laboratory of Molecular Cancer Epidemiology,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;YuceBio Technology Co.,Ltd.,Shenzhen 518172,China;Department of Epidemiology and Biostatistics,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;Sarcoma Multidisciplinary Program,Sylvester Comprehensive Cancer Center,The University of Miami,Miami,FL 33136,USA
Identification of hub genes and their novel diagnostic and prognostic significance in pancreatic adenocarcinoma
Duo Zuo;Yongzi Chen;Xinwei Zhang;Zhuozhi Wang;Wenna Jiang;Fan Tang;Runfen Cheng;Yi Sun;Lu Sun;Li Ren;Rui Liu-Department of Clinical Laboratory;Department of Tumor Cell Biology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;School of Biomedical Engineering,Tianjin Medical University,Tianjin 300070,China;Department of Pathology,Tianjin Huanhu Hospital,Tianjin 300350,China;Department of Pathology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;School of Pharmacy,Tianjin Medical University,Tianjin 300070,China;Department of Gastrointestinal Medical Oncology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China
Hypoxia-inducible factor-2α and its missense mutations: potential role in HCC diagnosis, progression, and prognosis and underlying mechanism
Jun Li;Yibo Yan;Ganxin Wang;Zaozao Huang-Emergency Department,Liyuan Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430077,China;Division of Cardiology,Liyuan Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430077,China;Division of Oncology,Liyuan Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430077,China;Cancer Center,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China;Yangchunhu Community Hospital,Liyuan Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430077,China
Towards a global One Health index: a potential assessment tool for One Health performance
Zhang Xiao-Xi;Liu Jing-Shu;Han Le-Fei;Xia Shang;Li Shi-Zhu;Li Odel Y.;Kassegne Kokouvi;Li Min;Yin Kun;Hu Qin-Qin;Xiu Le-Shan;Zhu Yong-Zhang;Huang Liang-Yu;Wang Xiang-Cheng;Zhang Yi;Zhao Han-Qing;Yin Jing-Xian;Jiang Tian-Ge;Li Qin;Fei Si-Wei;Gu Si-Yu;Chen Fu-Min;Zhou Nan;Cheng Zi-Le;Xie Yi;Li Hui-Min;Chen Jin;Guo Zhao-Yu;Feng Jia-Xin;Ai Lin;Xue Jing-Bo;Ye Qian;Grant Liz;Song Jun-Xia;Simm Geoff;Utzinger Jürg;Guo Xiao-Kui;Zhou Xiao-Nong-School of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China;One Health Center, Shanghai Jiao Tong University-The University of Edinburgh, Shanghai, People’s Republic of China;National Institute of Parasitic Diseases at Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), NHC Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre for Tropical Diseases, Shanghai, People’s Republic of China;Shanghai Legislative Research Institute, Shanghai, People’s Republic of China;Zhuhai Branch, ESPRE, Beijing Normal University Zhuhai Campus, Zhuhai, Guangdong, People’s Republic of China;Global Health Academy, The University of Edinburgh, Edinburgh, UK;Food and Agriculture Organization of the United Nations, Rome, Italy;Global Academy of Agriculture and Food Systems, The University of Edinburgh, Edinburgh, UK;Swiss Tropical and Public Health Institute, Allschwil, Switzerland;University of Basel, Basel, Switzerland
A multi-center, open-label, randomized, parallel-controlled phase Ⅱ study comparing pharmacokinetic, pharmacodynamics and safety of ripertamab (SCT400) to rituximab (MabThera?) in patients with CD20-positive B-cell non-Hodgkin lymphoma
Xiaohong Han;Mingzhi Zhang;Huaqing Wang;Qingyuan Zhang;Wei Li;Miaowang Hao;Yuhuan Gao;Jie Jin;Hanyun Ren;Yun Tang;Xiaonan Hong;Xiaoyan Ke;Hang Su;Lin Gui;Jianmin Luo;Liangzhi Xie;Wenlin Gai;Yuankai Shi-Clinical Pharmacology Research Center,Peking Union Medical College Hospital,State Key Laboratory of Complex Severe and Rare Diseases,NMPA Key Laboratory for Clinical Research and Evaluation of Drug,Beijing Key Laboratory of Clinical PK&PD Investigation for Innovative Drugs,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100730,China;Department of Oncology,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;Department of Medical Oncology,Tianjin People's Hospital,Tianjin 300121,China;Department of Medical Oncology,Harbin Medical University Cancer Hospital,Harbin 150081,China;Oncology Department of Cancer Center,the First Hospital of Jilin University,Changchun 130021,China;Department of Hematology,Tangdu Hospital,Air Force Medical University,Xi'an 710038,China;Department of Hematology,the Fourth Hospital of Hebei Medical University,Shijiazhuang 050011,China;Department of Hematology,the First Affiliated Hospital of Zhejiang University,Hangzhou 310003,China;Department of Hematology,Peking University First Hospital,Beijing 100034,China;Department of Hematology,West China Hospital,Sichuan University,Chengdu 610041,China;Department of Medical Oncology,Fudan University Shanghai Cancer Center,Shanghai 200032,China;Department of Hematology,Peking University Third Hospital,Beijing 100191,China;Department of Lymphoma,the Fifth Medical Center of PLA General Hospital,Beijing 100071,China;Department of Medical Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs,Beijing 100021,China;Department of Hematology,the Second Hospital of Hebei Medical University,Shijiazhuang 050000,China;Beijing Engineering Research Center of Protein and Antibody,Sinocelltech Ltd.,Beijing 100176,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。